Ticker Details
Rein Therapeutics, Inc. Common Stock
IPO Date:	August 26, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$31.81M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.07 | 4.43%
Avg Daily Range (30 D):	$0.05 | 4.04%
Avg Daily Range (90 D):	$0.05 | 3.80%

Institutional Daily Volume
Avg Daily Volume:	.06M
Avg Daily Volume (30 D):	.1M
Avg Daily Volume (90 D):	.61M

Trade Size
Avg Trade Size (Sh.):	182
Avg Trade Size (Sh.) (30 D):	214
Avg Trade Size (Sh.) (90 D):	169

Institutional Trades
Total Institutional Trades:	2
Avg Institutional Trade:	$.63M
Avg Institutional Trade (30 D):	$.68M
Avg Institutional Trade (90 D):	$.68M
Avg Institutional Trade Volume:	.5M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	K

News

Feb 9, 2026 @ 6:00 PM Idiopathic Pulmonary Fibrosis Clinical Trials & Pi... Source: Delveinsight

Aug 19, 2025 @ 12:00 PM Rein Therapeutics Wins U.K. Approval to Launch Pha... Source: Rein Therapeutics

Aug 14, 2025 @ 9:00 PM Rein Therapeutics to Present Novel IPF Science and... Source: Rein Therapeutics

Financials
	TTM	Q2 2025	Q1 2025
Basic EPS	$-.21	$-.28	$-.25
Diluted EPS	$-.21	$-.28	$-.25
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-5.58M	$-6.82M	$-5.5M
Operating Income / Loss	$-5.49M	$-6.87M	$-5.61M
Cost of Revenue
Net Cash Flow	$.03M	$M	$M
PE Ratio